Press Releases & Presentations

Press Releases & Presentations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors
Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors TUCSON, Ariz., Nov. 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired Read more
View HTML
Toggle Summary Accelerate Diagnostics Announces Final Results of Rights Offering
Accelerate Diagnostics Announces Final Results of Rights Offering TUCSON, Ariz., Aug. 13, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider Read more
View HTML
Toggle Summary Accelerate Diagnostics Announces Final Terms of Rights Offering
Company previously announced plans to raise $20,000,000 to fund product commercialization efforts Read more
View HTML
Toggle Summary Accelerate Diagnostics Joins the Russell 2000® Index
Accelerate Diagnostics Joins the Russell 2000 ® Index TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today Read more
View HTML
Toggle Summary Accelerate Diagnostics Appoints Chief Commercial Officer
Accelerate Diagnostics Appoints Chief Commercial Officer TUCSON, Ariz., July 1, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today. Most recently Pete was Sr. Read more
View HTML
Toggle Summary Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired Read more
View HTML
Toggle Summary Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors
Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors TUCSON, Ariz., March 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal Read more
View HTML
Toggle Summary Accelerate Diagnostics goes to NASDAQ
Accelerate Diagnostics to begin trading on NASDAQ under the ticker symbol AXDX on Wednesday, December 26, 2012. Read more
View HTML
Toggle Summary Accelr8 Announces New Management
Larry Mehren joins AXK as CEO and President. Brings track record of success as senior executive in diagnostic industry. Read more
View HTML
Toggle Summary Accelr8 Closes on Investment
Accelr8 closes on previously announced sale of common stock. Read more
View HTML
:

Day High:
Day Low:  
Volume:    

Copyright West LLC. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates